Fagron NV (EBR:FAGR)
20.60
-0.05 (-0.24%)
Aug 8, 2025, 5:35 PM CET
Fagron NV Revenue
Fagron NV had revenue of 476.13M EUR in the half year ending June 30, 2025, with 28.14% growth. This brings the company's revenue in the last twelve months to 918.75M, up 11.94% year-over-year. In the year 2024, Fagron NV had annual revenue of 871.96M with 14.28% growth.
Revenue (ttm)
918.75M
Revenue Growth
+11.94%
P/S Ratio
1.64
Revenue / Employee
230.32K
Employees
3,828
Market Cap
1.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 871.96M | 108.97M | 14.28% |
Dec 31, 2023 | 762.99M | 79.11M | 11.57% |
Dec 31, 2022 | 683.88M | 110.07M | 19.18% |
Dec 31, 2021 | 573.81M | 17.84M | 3.21% |
Dec 31, 2020 | 555.97M | 21.28M | 3.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 2.66B |
UCB SA | 6.85B |
Financière de Tubize | 13.26K |
Ion Beam Applications | 498.16M |
Nyxoah | 4.36M |
Onward Medical | 1.74M |
Hyloris Pharmaceuticals | 9.76M |
Sequana Medical NV | 105.50K |
Fagron NV News
- 2 months ago - Fagron increases share capital through exercise subscription rights - GlobeNewsWire
- 3 months ago - Fagron: Recent Capital Markets Day Confirms Upside Potential - Seeking Alpha
- 4 months ago - Record first-quarter revenue of €239 million, reflecting 14% topline growth - GlobeNewsWire
- 7 months ago - Fagron: FDA Warning Letter Creates New Entry Opportunity - Seeking Alpha
- 10 months ago - Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook - GlobeNewsWire
- 1 year ago - Record revenue of €209 million in first quarter reflecting 15% topline growth - GlobeNewsWire
- 1 year ago - Continued strong third quarter performance with 11% topline growth to €191 million - GlobeNewsWire
- 2 years ago - Fagron NV (ARSUF) Q2 2023 Earnings Call Transcript - Seeking Alpha